NCT02287233 2022-08-29A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous LeukemiaAbbViePhase 1/2 Completed94 enrolled 37 charts
NCT01411267 2022-04-04AC220 for Children With Relapsed/Refractory ALL or AMLTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Completed24 enrolled 14 charts
NCT01880437 2015-12-15A Study of Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myelodysplastic SyndromeHoffmann-La RochePhase 2 Terminated38 enrolled 11 charts